Introduction
Dermatologic surgery in infants and children is becoming more frequent, mainly because skin lesions increase in size proportionally with age and skin growth, leading to considerably larger excision wounds; their early removal therefore leads to very good cosmetic results due to increased skin elasticity and excellent tissue regeneration [1] . The most frequently excised lesions in children are congenital and sebaceous nevi, Spitz nevi, acquired melanocytic nevi and dermoid or epidermal cysts [2] . Pediatricians and dermatologists should be aware of the indications for surgery or laser therapy in infants as well as the optimal timing of these procedures (Table 1) .
Furthermore, attention should be paid when administering analgesics, anesthetics or sedative drugs in children with respect to the particular drug pharmacokinetics and pharmacodynamics. There are still several concerns regarding potential anesthetic complications in children undergoing surgery. Drugs used for sedation or general anesthesia might carry a risk of impaired mental development in children later in life [3] . These concerns were raised by experimental findings with rodents. Population studies in humans have not yet shown a risk of mental handicap after early childhood anesthesia for hernia repair and other procedures, but large studies in North America are still running and the results are still pending [3] . Based on our experience and a literature review, we illustrate the most commonly used analgesic, anesthetic and sedative drugs in pediatric dermatosurgery, and identify risk factors and complications following dermatosurgical procedures.
Common surgical procedures and postoperative complications in pediatric patients
Most excisions in children have a direct surgical closure. In most cases the suture technique is an interrupted absorbable suture, followed by surface continuous intradermal absorbable suture or acrylic tissue adhesives -especially at an early age when removing sutures might be traumatizing [4, 5] .
The most frequent surgical complications in children are scar stretching, development of hypertrophic scars/keloids or local infections that sometimes need reintervention or antibiotics ( Figure 1) .
With regard to scar stretching and dehiscence, it is known that the scar's width correlates exponentially with the tension on the suture line, and the tension correlates linearly with the resection. There is therefore no significant difference between intradermal, continuous or interrupted sutures [6] . In low tension areas (face, neck), there is no significant aesthetic difference between the use of intradermal absorbable or interrupted non-absorbable suture [6] . Where scars are located in high tension areas (limbs) with increased mobility, patients are more prone to develop surgical and scar complications. There is also a tendency toward increased postoperative complications in older children due to the increased activity in this age group [5] . Nevus sebaceus -benign hamartoma showing increased risk of basal cell carcinoma development in adulthood -small lesions: removed in adolescence with local anesthesia -large lesions (> 1.5 cm): removed in infancy due to increased skin elasticity and better wound closure potential [41] Port-wine stains -capillary malformations of newborns -grow proportionally with the infants and do not involute -increased psychosocial distress due to aesthetic appearance -pulse-dye laser in infancy to prevent thickening and nodularity -neodymium-doped yttrium aluminum garnet lasers for thickened port-wine stains with vascular blebs [42] Infantile hemangiomas -most common benign tumor of infancy; can involute 10 % per year -topical timolol for superficial hemangiomas -Oral propranolol (1-2 mg/kg/day, divided into 3 doses) [43] -excision of redundant fibro-fatty tissue following hemangioma involution
Topical anesthetics
Topical anesthetics are safely and effectively used in children prior to infiltrative anesthesia for dermatologic procedures, and decrease preoperative discomfort and anxiety [7] . They act by blocking the voltage-gated sodium channels responsible for conducting electrical impulses. Traditional agents used in children include a eutectic mixture of local anesthetics (EMLA), lidocaine formulations and vapor-coolants. EMLA contains two amide-type local anesthetics (2.5 % lidocaine, 2.5 % prilocaine); applied to intact skin under occlusion, it accumulates in the proximity of dermal nociceptors and leads to dermal analgesia. The analgesic duration depends on the duration of application; sufficient analgesia is achieved after one hour of occlusive application, and persists for 1-2 hours. For genital mucosa, the onset of analgesia is much faster (10 minutes). Applying EMLA to inflamed skin can lead to increased absorption and higher plasma levels, resulting in systemic responses. In several controlled studies, application of EMLA in children for one hour prior to needle insertion led to a significant reduction of pain compared to placebo. In a study involving 73 infants (5-16 years), application of EMLA for laser treatment of facial port-wine stains was also effective in providing pain relief [8] . Other groups showed that non-ablative laser or other minor surgical procedures (curettage) can be performed in children under topical anesthesia only [9] .
The most common prilocaine-related side effect of EMLA is increased levels of methemoglobin (MetHb) in infants [10] due to the immaturity of the NADH reductase enzyme, and the use of EMLA in children < 3 months of age is not recommended due to the increased risk of methemoglobinemia. Taddio et al. showed in a systematic review that EMLA doses of 0.5 g to 2 g do not lead to an increase of methemoglobin in neonates [11] . According to Lilieborg et al., the maximum dosages of EMLA that can be safely administered are 2 g in children 2-11 months of age, 10 g for the age group 1-5 years, and 20 g over the age of 6 [10] . Caution is advised when applying EMLA to patients with glucose-6-phosphate dehydrogenase deficiencies or in combination with other MetHB-inducing medications (sulfametoxazole, antimalarials) due to possible additive effects [10] .
ELA-Max (4 % liposomal lidocaine) applied for 30 minutes to intact skin with occlusion diminishes pain associated with needle puncture as effectively as EMLA and is thus functionally equivalent [12] . Large amounts of ELA-Max may increase lidocaine levels and should not be used on mucous membranes [13] .
Vapor coolants may be used to control minor pain in children undergoing intravenous cannulation or local anesthesia. They can be sprayed onto the skin prior to needle insertion, resulting in a significant cooling effect and pain relief. The needle insertion should occur immediately following application. The advantage of vapor coolants is their immediate effect, but they should be used with caution since these sprays are highly inflammable. Griffith et al. performed an extensive literature search and collected data from nine studies comparing vapor coolants with placebo spray in children and adults undergoing intravenous cannulation, and showed that application of vapor coolants before intravenous cannulation significantly reduced pain associated with the procedure [14] .
However, another publication compared the effectiveness of vapor coolant sprays and EMLA for pain reduction during venous cannulation in 40 children with thalassemia (6-12 years) and showed that vapor coolant spray was not as effective as EMLA in reducing pain [15] . Nevertheless, vapor coolants are a good alternative for children with known allergic reactions to lidocaine and procaine. 
Local anesthetics
Local anesthetics provide temporary anesthesia in a particular body area without affecting consciousness. Several local anesthetics are now available for pain management in pediatric dermatology; these are classified as esters (benzocaine, tetracaine, procaine) or amides (lidocaine, prilocaine, articaine, mepivacaine), which are less allergenic. Local anesthetics are vasodilators. They are absorbed into the blood stream and can cause systemic effects above a certain plasma level [16] . Vasoconstrictors (epinephrine, norepinephrine) are added to local anesthetics in dermatologic surgery to provide vasoconstriction in the area of injection; they reduce the absorption rate into the blood stream and thus the toxicity of the agents. They also increase the duration and quality of anesthesia and decrease the amount of blood loss. The addition of epinephrine to local anesthesia is safe for use with hands, feet, digits and the penis, as well as for reconstruction of the nose or ear, leading to decreased surgical time and blood loss [17, 18] . According to the work group of Kouba et al., epinephrine in low concentrations (1 : 100,000, 1 : 200,000) is safe for dermatologic surgery [7] . However, a concentration of 1 : 100,000 should not be exceeded in children in order to avoid vasoconstriction toxicity (tachycardia, hypertension, anxiety, arrhythmias, tremor etc.) [19] .
Local anesthetics are bound to serum proteins, mainly α1-acid-glycoprotein or serum albumin; since neonates have lower concentrations of serum α1-acid-glycoprotein, the free fraction of local anesthetics is significantly higher than in adults. The main local anesthetics used in pediatric dermatological procedures are lidocaine, bupivacaine, ropivacaine, mepivacaine, prilocaine and articaine.
Lidocaine (0.5 to 2 %) is an amide with a rapid onset and medium duration of action. It is applied for peripheral blocks or dermatologic procedures in infants. The recommendation for lidocaine dosage in office-based pediatric surgery is to use no more than 1.5-2.0 mg/kg of lidocaine and 3.0-4.5 mg/ kg of lidocaine with epinephrine in a single treatment. Infiltrative anesthesia can be combined with topical anesthesia as long as the maximum dosage is respected [7] .
Bupivacaine (0.1 to 0.5 %) has a longer onset time and duration than lidocaine, but also a greater potential for severe cardiotoxicity than other agents; levobupivacaine is less toxic and a better alternative to bupivacaine.
Ropivacaine (0.2 to 1.0 %) has a similar onset time and duration of action to bupivacaine; it produces less motor blockade and is less toxic. Ropivacaine is used for peripheral blocks and caudal/epidural anesthesia as well as analgesia. In infants and children, ropivacaine is the most common anesthetic used in dermatologic procedures since it provides significant postoperative analgesia. In children aged 1 month-15 years, ropivacaine is generally well tolerated, with a low incidence of side effects [7] that include bradycardia and jaundice. According to Simpson et al., the side effects of ropivacaine and bupivacaine occur with similar frequencies [20] .
Mepivacaine is as potent as lidocaine and is used for peripheral nerve blocks, especially in dental pediatric procedures.
Prilocaine can induce methemoglobin formation, leading to symptoms of methemoglobinemia at doses greater than 6 mg/kg. Prilocaine is contraindicated in patients receiving acetaminophen and phenacetin, since both drugs are known to increase methemoglobin levels [21] .
Articaine is a short-acting local anesthetic in the amide group. When combined with 1 : 100,000 epinephrine, it is effective in cutaneous dermatologic procedures. The effect appears in 2-4 minutes and lasts for approximately 71 minutes [22] . Table 2 shows the most commonly used infiltration anesthetics in children.
Pediatric dermatologists should be well aware of the proper dosage of local anesthetics (weight-adjusted) in order to Table 2 Most frequently used infiltration anesthetics in children: time of onset, duration and dosage recommendations [44] . Appropriate knowledge of anatomy allows proper placement of the anesthetic in order to avoid complications such as intravascular injection, hematomas or nerve injuries [23] . Another aspect to be considered is the technique of local administration of anesthetics in infants: factors such as distraction of the pediatric patient, use of small cannulas, pH adjustment and comfortable room temperature can positively influence the behavior of pediatric patients receiving anesthesia.
Adverse reactions to local anesthetics
Most adverse reactions to local anesthetics appear during injection or within the first 5-10 minutes [24] . Local anesthetic toxicity is rare, but seizures, arrhythmia, cardiovascular collapse and neuropathic symptoms have been described. This can be explained by the delay in metabolism/elimination of anesthetics in young children due to decreased concentrations of α1-acid-glycoprotein and consequent increased concentrations of free unbound anesthetic agent. A known allergy to local anesthetics is an absolute contraindication for local anesthesia. While amide allergy is extremely rare and allergy to one amide does not rule out the use of other amides, allergy to ester anesthetics is a direct contraindication for any ester anesthetic agent [9] . In Table 3 an overview of potential complications from local anesthetics in pediatric surgery is given.
If an anesthetic toxicity reaction occurs, delivery of the anesthetic must be stopped immediately, and the patient must be given oxygen or resuscitated in case of cardiac arrest. In case of generalized seizures, anticonvulsants should be administered (midazolam 0.15 mg/kg i.v. (max. 10 mg) or 0.3 mg/ kg buccal or intranasal (max. 10 mg) [25] .
Lipid emulsions (20 %) are successful antidotes for local anesthetic intoxication. According to the literature, lipid emulsions can extract/absorb the circulating lipophilic anesthetics/toxins, reducing the unbound free toxin available Table 3 Overview of potential complications from local anesthetics in pediatric surgery.
Complications during local anesthesia

Symptomatology
Therapeutic approach to complications
Overdose by intravascular injection -dizziness, anxiety, confusion, nausea, convulsions -cardiovascular manifestations: increased blood pressure and heart rate, then, as plasma levels increase, subsequent fall in blood pressure with bradycardia and in severe cases cardiac arrest [26] -airway management -anticonvulsant (benzodiazepines) -management of cardiac dysrhythmias -lipid emulsion therapy -emergency medical services Epinephrine overdose -fear, anxiety, restlessness, tremor, perspiration, palpitations -terminate treatment -position patient upright -airway management and oxygen administration -emergency medical services Syncope/vasovagal attack -pallor, hyperhidrosis, hyperventilation, hypotension -Trendelenburg position -airway management -intravenous 20 mL 20-50 % glucose in case of hypoglycemia [45] Hypersensitivity reactions/ allergy -urticaria, dermatitis, fever, photosensitivity, angioedema, anaphylaxis.
-diphenhydramine -epinephrine/corticosteroid
Nerve injury/hemorrhage -paresthesia leading to the appearance of an electric shock sensation in the nerve distribution area -topical lidocaine -pregabalin/gabapentin -tramadol/opioid -interventional pain therapies [46] Postoperative soft tissue injury -lip and cheek-biting lesions especially as a consequence of local anesthesia in the oral cavity -lubrification of area -prevention of drying, cracking, pain
Accidental intravascular injection -soft tissue necrosis -local wound care
to bind to sites such as the myocardium, and lowering the cardiotoxicity. The emulsions are administered at a dosage of 1.5 mL/kg as a bolus, then infused as 0.1 mL/g/min for 30 minutes or 0.5 mL/kg/min for ten minutes [26] .
Regional anesthesia
Even though local infiltration anesthesia is commonly used in dermatosurgical procedures, there are circumstances where a nerve block can provide more effective anesthesia. In such cases, local anesthetic is injected adjacent to the nerves which supply the surgical field [27] . Nerve blocks can be used to minimize pain associated with the injection of infiltration anesthesia when operating on larger areas such as the face, scalp, fingers or toes, providing anesthesia with a longer duration. Performing nerve blocks requires a very good knowledge of the anatomy of the surgical field. Some of the most common nerve blocks in children undergoing dermatosurgical procedures are listed in Table 4 . Tumescent anesthesia, which involves infiltration of large amounts of local anesthetic into the subcutaneous tissue of the surgical area, can also be used in pediatric patients, leading to significant and prolonged perioperative analgesia, little bleeding and anesthesia of a large area [1, 28] . According to Heister et al., solutions for tumescent anesthesia in different concentrations (0.05 % to 0.30 %) can be effectively used even in children less than seven months old [1] . The 0.05 % solution of Heister et al. comprises 10 mL ropivacaine 1 %, 10 mL lidocaine 2 %, 0.5 mL epinephrine 1 : 1,000 and 500 mL isotonic complete electrolyte solution.
General anesthesia
General anesthesia is performed in children who are too young for administration of a local anesthetic, in case of large skin lesions that require excision, or in cases of multiple laser treatments that would otherwise expose the child to several painful interventions. The risk of complications following general anesthesia in children is usually low because most patients are healthy with no comorbid diseases and the dermatological procedures are usually brief.
In a multicenter retrospective review comprising 269 children and adolescents (2 months to 18 years), Cunningham et al. found that the mortality rate associated with general anesthesia was 0 % and mild perioperative complications only appeared in about 4 % of subjects [29] . Tiret's group performed a prospective study on 40,240 cases where general anesthesia was performed in children < 15 years of age, and showed that the complication rate increases significantly according to the ASA class of the patient as well as the number of coexisting diseases [30] . Bradycardia risk was also investigated in children undergoing anesthesia, and a significantly higher rate of bradycardia was noted in subjects with ASA class III-IV than in subjects with ASA class I-II [31] . A recently published work studied the neurocognitive outcomes in children 8-15 years of age, and compared children who had undergone general anesthesia for inguinal hernia surgery before the age of three with siblings who had not undergone anesthesia. There were no statistically significant differences in neurodevelopmental outcomes between the exposed and unexposed groups [32] . Table 4 Main blocks used in pediatric dermatologic surgery [47] .
Type of block Anestheticum Technique
Digital block (fingers, toes) -2 % lidocaine + 1/4 bupivacaine with 1 : 200,000 epinephrine [48] -1 mL anesthetic injected into web space on both sides of proximal digit, at superior aspect of interphalangeal crease -massage of injected areas -topical anesthetic applied to labial sulcus superior to canine fossa -needle advancement superiorly 1-2 cm from infraorbital foramen and injection of lidocaine
However, according to several other studies, general anesthesia should be avoided in children < 12 months old in order to decrease the general risks of anesthesia as well as potential adverse effects on neurological development [3, 33] . Due to the lack of sufficient studies centered in the neonatal period and the first year of age, caution is advised in this age group due to potential long-term neurological side effects. Tumescent anesthesia can be successfully used in children, as shown by Heister et al. [1] .
Peri-and postoperative analgesia
Based on the child's pain level, analgesics are divided into non-steroidal anti-inflammatory drugs (NSAIDS) for mild to moderate pain, and opioids for moderate to severe pain. NSAIDS such as acetaminophen or ketorolac can be used in older children and adults, but should be avoided in neonates due to their known side-effects. Inhibition of prostaglandins in neonates may lead to dysfunction of central blood flow, impaired renal function, disrupted thermoregulation and disorders of hemostasis [34] . For maintenance of analgesia, short-acting opioids such as fentanyl, a highly lipophilic agent, cause less central respiratory depression than morphine and can be used as an infusion (0.2-2.0 μg/kg) [35] . For perioperative pain therapy, nalbuphine is considered to be a nearly ideal opioid because of its pharmacological properties and high safety profile [36] . However, these short-acting opioids should only be administered by specially trained pediatric anesthetists with close patient monitoring (respiratory rate, pulse oximetry, electrocardiogram) in order to avoid serious complications of opioid therapy such as respiratory depression, apnea, tachycardia, nausea or vomiting. In case of apnea, the pediatric anesthetist should assist ventilation with a mask ventilation system, and also administer intravenous naloxone if necessary in order to counteract ventilatory depression [37, 38] .
Recommended doses of analgesic drugs commonly used in children are summarized in Table 5 .
Conclusions
Several dermatologic conditions such as melanocytic nevi, nevus sebaceus, port-wine stains and hemangiomas require excisional or laser surgery in children. Some conditions can be medically managed, while surgical excision or laser treatment may be necessary in other cases. In children, particular attention should be paid to the doses of local anesthetics. In order to avoid potential overdosing, a maximum recommended dose based upon body weight should be calculated. Topical anesthetics can be used in children for superficial dermatologic procedures such as curettage, or prior to infiltration anesthesia in order to diminish the discomfort associated with needle penetration. The use of vasoconstrictors together with local anesthetics is recommended in order to decrease the potential toxicity of the anesthetic drug. The use of general anesthesia in dermatologic procedures has a low rate of side effects, but caution is advised in children under the age of one due to potential long-term neurological side-effects and lack of sufficient studies centered in the neonatal period and first year of age. Tumescent anesthesia can be successfully used in children and even in infants undergoing dermatosurgical procedures. For perioperative pain control, NSAIDs and opioids play a significant role in pediatric analgesia.
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